Letters Polypharmacy and acute kidney injury

Authors’ reply to Moore

BMJ 2013; 346 doi: http://dx.doi.org/10.1136/bmj.f1016 (Published 19 February 2013) Cite this as: BMJ 2013;346:f1016
  1. Francesco Lapi, pharmacoepidemiology fellow1,
  2. Laurent Azoulay, assistant professor1,
  3. Samy Suissa, professor and director1
  1. 1Centre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montreal, QC, Canada, H3T 1E2
  1. samy.suissa{at}mcgill.ca

We would like to respond to Moore’s thoughtful comments.1 2

Firstly, we considered this important point in our analyses—we adjusted the models for the use of drugs related to the indications for non-steroidal anti-inflammatory drugs (NSAIDs). These included antibiotics (related to short term infections) and immunosuppressive agents (related to conditions associated with …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe